Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations. DIFLUNISAL USP GDUFA DMF Review :N/A Rev. Date : Pay. Date : DMF Number :34818 Submission :2020-04-20
Y bedeutet vorzugsweise Het2, N(R2)2, NR2(C(R2)2]nN(R2)2 oder C(=O)N(R2)2, worin eine NH-Gruppe durch N-COOA oder N-COA ersetzt sein kann.R4, R5 bedeuten vorzugsweise, jeweils unabhängig voneinander H oder Hal.
(R3)2]nHet1, CO-Het1, CHO, COA, ═S, ═NH, ═NA and/or ═O, and where a ring nitrogen is optionally oxidized, Het1 denotes a monocyclic saturated heterocycle having 1 to 2 N and/or O atoms, which is unsubstituted or mono- or disubstituted by A, OA, OH, Hal and/or ═O,...
ProMetic LifeSciences) promoter, Procyon) Bortezomib (proteasome Doranidazole (apoptosis inhibitor, Millennium) SRL-172 (T-cell stimulant, SR promoter, Pola) Pharma) CHS-828 (cytotoxic TLK-286 (glutathione-S agent, Leo) transferase inhibitor, Telik) trans-Retinic acid PT-100 (growth factor (...
(54) acetyl-CoA carboxylase (ACC) inhibitors such as CP640186, CP610431, CP640188 (Pfizer); (55) C-terminal growth hormone fragments such as AOD9604 (Monash Univ/Metabolic Pharmaceuticals), and the like; (56) oxyntomodulin; (57) neuropeptide FF receptor antagonists such as those disclosed ...